These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 27798725

  • 1. Comparisons of the outcomes between early and late tocilizumab treatment in systemic juvenile idiopathic arthritis.
    Pacharapakornpong T, Vallibhakara SA, Lerkvaleekul B, Vilaiyuk S.
    Rheumatol Int; 2017 Feb; 37(2):251-255. PubMed ID: 27798725
    [Abstract] [Full Text] [Related]

  • 2. Longterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan.
    Yokota S, Imagawa T, Mori M, Miyamae T, Takei S, Iwata N, Umebayashi H, Murata T, Miyoshi M, Tomiita M, Nishimoto N, Kishimoto T.
    J Rheumatol; 2014 Apr; 41(4):759-67. PubMed ID: 24634205
    [Abstract] [Full Text] [Related]

  • 3. Discrepancy between clinical and radiological responses to tocilizumab treatment in patients with systemic-onset juvenile idiopathic arthritis.
    Aoki C, Inaba Y, Choe H, Kaneko U, Hara R, Miyamae T, Imagawa T, Mori M, Oba MS, Yokota S, Saito T.
    J Rheumatol; 2014 Jun; 41(6):1171-7. PubMed ID: 24786929
    [Abstract] [Full Text] [Related]

  • 4. Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis.
    Ruperto N, Brunner HI, Ramanan AV, Horneff G, Cuttica R, Henrickson M, Anton J, Boteanu AL, Penades IC, Minden K, Schmeling H, Hufnagel M, Weiss JE, Pardeo M, Nanda K, Roth J, Rubio-Pérez N, Hsu JC, Wimalasundera S, Wells C, Bharucha K, Douglass W, Bao M, Mallalieu NL, Martini A, Lovell D, Benedetti F, Paediatric Rheumatology INternational Trials Organisation (PRINTO) and the Paediatric Rheumatology Collaborative Study Group (PRCSG).
    Rheumatology (Oxford); 2021 Oct 02; 60(10):4568-4580. PubMed ID: 33506875
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Safety of tocilizumab in the treatment of juvenile idiopathic arthritis.
    Machado SH, Xavier RM.
    Expert Opin Drug Saf; 2017 Apr 02; 16(4):493-500. PubMed ID: 28277841
    [Abstract] [Full Text] [Related]

  • 7. Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry.
    Horneff G, Schulz AC, Klotsche J, Hospach A, Minden K, Foeldvari I, Trauzeddel R, Ganser G, Weller-Heinemann F, Haas JP.
    Arthritis Res Ther; 2017 Nov 22; 19(1):256. PubMed ID: 29166924
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of tocilizumab on growth impairment in systemic juvenile idiopathic arthritis with long-term corticosteroid therapy.
    Miyamae T, Yokoya S, Yamanaka H, Yokota S.
    Mod Rheumatol; 2014 Jul 22; 24(4):567-71. PubMed ID: 24252004
    [Abstract] [Full Text] [Related]

  • 11. Reasons for inactive disease and flare in systemic onset juvenile idiopathic arthritis patients during tocilizumab treatment.
    Kostik MM, Isupova EA, Chikova IA, Dubko MF, Masalova VV, Snegireva LS, Kalashnikova OV, Chasnyk VG.
    Clin Exp Rheumatol; 2018 Jul 22; 36(2):335-341. PubMed ID: 29303703
    [Abstract] [Full Text] [Related]

  • 12. Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
    Tappeiner C, Mesquida M, Adán A, Anton J, Ramanan AV, Carreno E, Mackensen F, Kotaniemi K, de Boer JH, Bou R, de Vicuña CG, Heiligenhaus A.
    J Rheumatol; 2016 Dec 22; 43(12):2183-2188. PubMed ID: 27633821
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of tocilizumab in Chinese patients with systemic juvenile idiopathic arthritis: a multicentre phase IV trial.
    Li C, Tang X, Zhou Z, Sun L, Lu M, Zhou W, Yang S, Zheng W, Yu H, Tan W, Zhang J, Zhang Y, Kong Y, Xu J.
    Clin Rheumatol; 2024 Nov 22; 43(11):3457-3467. PubMed ID: 39279018
    [Abstract] [Full Text] [Related]

  • 14. Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan.
    Yokota S, Itoh Y, Morio T, Origasa H, Sumitomo N, Tomobe M, Tanaka K, Minota S.
    Ann Rheum Dis; 2016 Sep 22; 75(9):1654-60. PubMed ID: 26644233
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Systemic onset juvenile idiopathic arthritis: a single center experience.
    Sağ E, Uzunoğlu B, Bal F, Sönmez HE, Demir S, Bilginer Y, Özen S.
    Turk J Pediatr; 2019 Sep 22; 61(6):852-858. PubMed ID: 32134578
    [Abstract] [Full Text] [Related]

  • 18. Tocilizumab for juvenile idiopathic arthritis: a single-center case series.
    Yazılıtaş F, Özdel S, Şimşek D, Aydoğ Ö, Çakıcı EK, Can GG, Güngör T, Bülbül M.
    Sao Paulo Med J; 2019 Sep 22; 137(6):517-522. PubMed ID: 32159638
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III Trial.
    Brunner HI, Ruperto N, Zuber Z, Cuttica R, Keltsev V, Xavier RM, Burgos-Vargas R, Penades IC, Silverman ED, Espada G, Zavaler MF, Kimura Y, Duarte C, Job-Deslandre C, Joos R, Douglass W, Wimalasundera S, Bharucha KN, Wells C, Lovell DJ, Martini A, de Benedetti F, Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).
    Arthritis Rheumatol; 2021 Mar 22; 73(3):530-541. PubMed ID: 32951358
    [Abstract] [Full Text] [Related]

  • 20. IL-6 blockade in systemic juvenile idiopathic arthritis - achievement of inactive disease and remission (data from the German AID-registry).
    Bielak M, Husmann E, Weyandt N, Haas JP, Hügle B, Horneff G, Neudorf U, Lutz T, Lilienthal E, Kallinich T, Tenbrock K, Berendes R, Niehues T, Wittkowski H, Weißbarth-Riedel E, Heubner G, Oommen P, Klotsche J, Foell D, Lainka E.
    Pediatr Rheumatol Online J; 2018 Apr 05; 16(1):22. PubMed ID: 29622022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.